Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study
Clinical trial NCT04513301 · UNKNOWN
Trial details
- NCT number
- NCT04513301
- Sponsor
- Shanghai Cancer Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-08-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.